K-pop

TOURS’ New Album Title Track Is “Call My Name”… Lyrics Co-Written by Youngjae, Shin Yu, and Do-hoon

Single Featuring 3 Tracks… to Be Released on the 2nd of Next Month

KIM HYUNSIK
2026-10-24 17:34:52
[Edaily Starin KIM HYUNSIK Reporter] The group TWS (Shin-yu, Do-hoon, Young-jae, Han-jin, Ji-hoon, Kyung-min) has revealed the tracklist for their new album.
(
Photo courtesy of Pledis Entertainment
)
(Photo courtesy of Pledis Entertainment)
At 10:00 p.m. on the 23rd, TWS posted an image of the tracklist for their second single, “TO US,” on the group’s official social media channels.
According to the image, TOUS has included three tracks on their new single: “Call My Name,” “WE UP,” and “heavy.”
The title track is “Call My Name,” for which members Youngjae, Shin-yu, and Do-hoon contributed to the lyrics.
Their agency, Pledis Entertainment, described the song as “a track that expresses the feeling that one can find courage in any situation because there is someone who believes in them.”
They added, “The members who contributed to the lyrics poured their hearts into the song for ‘42’ (their fan club name), who always stand by their side.”
TOURS will release the new single and the music video for the title track at 6:00 p.m. on the 2nd of next month. Prior to that, they will hold the final concert of their first Asian tour at the Kaohsiung Arena in Taiwan on the 24th. This tour consisted of a total of 15 shows across various locations, including Kaohsiung, Seoul, Fukuoka, Hyogo, Kanagawa, Macau, Bangkok, and Singapore.

Economy

Corporation

IT·Science

Economy

[VC's Pick] LegalTech Firm 'Legora' Expands into Korea, Secures Series E Funding

This week (October 19–23), startups in various sectors—including accommodation solutions, AI video production, and digital healthcare—secured investments from venture capital (VC) firms and accelerato…
2026-10-24 13:07:04

Corporation

“Do I Really Need a Styler?”… I Tried This One in the 20,000-won Range [Product Review]

We’re in an era of recession-driven consumption, where we want a lot but our wallets are light. Our reporter personally tests and evaluates “value-for-money alternatives” that let you keep up with tre…
2026-10-24 10:00:03

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02